Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

116.40 -0.43 (-0.37%)
Official Closing Price Updated: 7:00 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and other supply disruptions at MedTech companies.... 
Via Benzinga
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19... 
Via Benzinga
Exposures COVID-19 Product Safety
FDA Warns On Potential False Positive Results With Abbott's COVID-19 Tests
The FDA has issued a letter to healthcare professionals alerting them to the potential for false-positive results with Abbott Laboratories (NYSE: ABT) two COVID-19... 
Via Benzinga
Exposures COVID-19 Product Safety
3 Top Growth Stocks You Can Buy and Hold Forever
There will be no need to check on how they're doing every day. 
Via The Motley Fool
Where Abbott Laboratories Stands With Analysts
Within the last quarter, Abbott Laboratories (NYSE:ABT) has ... 
Via Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
Exposures COVID-19
Notable Abbott Laboratories Insider Trades $4.14 Million In Company Stock
Michael J Pederson, Senior Vice President at Abbott Laboratories (NYSE:ABT), made a large buy and sell of company shares on September 8, according to a new SEC filing. What... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Got $3,000? Keep It Safe With These 3 Healthcare Stocks
They offer products that their customers absolutely can't do without, and they also pay dividends. 
Via The Motley Fool
3 Dividend Stocks to Buy and Hold Forever
They all have solid dividends plus attractive growth prospects. 
Via The Motley Fool
Why Biden's Action Plan Is Bullish For COVID-19 Testing Stocks
On Thursday, President Joe Biden revealed his new COVID-19 action plan, which includes $2 billion in government spending on 280 mi... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
This Smart Monitor Company Has Outperformed Apple, Google And Amazon Over The Last 5 Years
A smart monitor company that received FDA approval in 2015 has seen a five-year stock performance that has outperformed the returns of Apple Inc (NASDAQ: AAPL), Alphabet Inc (... 
Via Benzinga
Exposures Product Safety
Abbott Labs Stock Strength Rises Into New Percentile As Health Care Giant Expands Organically And Via Acquisition
Additionally, Chicago-based Abbott Labs stock carries a near-perfect 98 Composite Rating, putting it in the top 2% of all stocks. 
Via Investor's Business Daily
Shares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High
Abbott Laboratories (NYSE: ABT) traded today at a new 52-week high of $129.40. Approximately 642,000 shares have changed hands today, as compared to an average 30-day volume of 4.... 
Via Benzinga
Why Shares of Quidel Surged 10% This Week
Demand for its COVID tests are rising with cases. 
Via The Motley Fool
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
This May Be Abbott's Billion-Dollar Opportunity
Abbott delivered bad news back in June. But the tide has turned. 
Via The Motley Fool
Exposures COVID-19
Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study
Abbott Laboratories (NYSE: ABT) has announced late-breaking data from the Amulet LAA Occluder IDE trial. The head-to-head study compared Abbott's Amplatzer... 
Via Benzinga
See Why CVS Is Limiting Purchase Of OTC COVID-19 Tests
CVS Health Corp (NYSE: CVS) is capping purchases of rapid, over-the-counter COVID-19 tests, with a maximum of six packages available online and four in its pharmacies. The... 
Via Benzinga
Exposures COVID-19
Healthcare Stocks Hit New Highs but Small Caps Lag
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field. 
Via Talk Markets
Abbott Destroyed Several COVID Test Cards, Now Faces Diminished Capacity: NYT
When demand for rapid COVID-19 screening dropped earlier this year, Abbott Laboratories (NYSE: ABT) lowered its financial outlook for full-year 2021 and ... 
Via Benzinga
Exposures COVID-19
AbbVie: Dividend Stock to Buy?!
The quest to find undervalued dividend stocks to buy in this hot stock market continues. The S&P 500 continues to trend higher and set record highs, even though we’ve had a few down days recently. 
Via Talk Markets
Topics Stocks
Exposures US Equities
FDA Approves Abbott's Atrial Fibrillation Device For LAA Occlusion
The 
Via Benzinga
Exposures Product Safety
How Spinoffs Affect Your Stocks
When stocks you own spins off a segment or division of its business, the company you own changes. This can change not only the future prospects of the company you own but also its historical... 
Via Talk Markets
2 Stocks That Could Turn $200,000 Into $1,000,000 in 10 Years
Both of these companies know something about beating the market. 
Via The Motley Fool
1 Healthcare Dividend Giant to Bank On Right Now
The pipeline and consistent dividend history of this Dividend Aristocrat mean its payout is likely to remain strong. 
Via The Motley Fool
Moderna’s (MRNA) Massive Market Cap
As could have been expected in the midst of a global pandemic, one of the most rapidly growing companies has been vaccine producer Moderna. 
Via Talk Markets
Got $5,000? Buy and Hold These 3 Market-Beating Stocks
They're likely to continue to outperform the market. 
Via The Motley Fool
Analyzing Abbott Laboratories's Unusual Options Activity
Shares of Abbott Laboratories (NYSE:ABT) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $120.62. Sentiment:... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.